METROPOLITAN LIFE INSURANCE CO/NY - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 97 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$17,515
+19.5%
2,3260.0%0.00%0.0%
Q2 2022$14,654
-24.1%
2,3260.0%0.00%0.0%
Q1 2022$19,306
-81.1%
2,326
-72.1%
0.00%
-50.0%
Q4 2020$102,314
+51.0%
8,3250.0%0.00%
+100.0%
Q3 2020$67,766
-15.2%
8,3250.0%0.00%0.0%
Q2 2020$79,920
-33.4%
8,325
+3.4%
0.00%
-50.0%
Q4 2019$120,020
+28.1%
8,055
-11.9%
0.00%0.0%
Q3 2019$93,675
+343.4%
9,139
+358.6%
0.00%
Q2 2019$21,1251,9930.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Vivo Capital, LLC 1,787,091$14,118,0003.56%
INTERWEST VENTURE MANAGEMENT CO 1,599,592$12,637,0002.99%
SPHERA FUNDS MANAGEMENT LTD. 385,301$3,044,0000.52%
Boxer Capital, LLC 138,331$1,093,0000.26%
DAFNA Capital Management LLC 35,977$284,0000.20%
SABBY MANAGEMENT, LLC 223,100$1,762,0000.12%
Hikari Power Ltd 60,992$482,0000.06%
Perceptive Advisors 157,679$1,245,0000.06%
Lombard Odier Asset Management (USA) Corp 90,000$711,0000.06%
TFS CAPITAL LLC 12,128$96,0000.04%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders